𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chemoresistance is not a cause of the apparent failure of adjuvant chemotherapy in postmenopausal women

✍ Scribed by Hug, Verena; Thames, Howard D.; Polyzos, A.; Johnston, Dennis

Book ID
122839442
Publisher
Elsevier Science
Year
1988
Weight
643 KB
Volume
24
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Anastrozole is safer and may be more eff
Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer: Abstracted from: Baum M, Buzdar A, Cuzick J, et al. The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer. Cancer 2003;98:1802–10
✍ Hetty Carraway; Antonio C. Wolff πŸ“‚ Article πŸ“… 2004 πŸ› Elsevier Science 🌐 English βš– 151 KB
Systemic chemotherapy following non-cura
Systemic chemotherapy following non-curative resection may increase survival for people with gall bladder carcinoma, but not carcinomas of the pancreas, bile duct or ampulla of Vater: Abstracted from: Takada T, Amano H, Yasuda H et al. Is postoperative adjuvant chemotherapy useful for gall bladder carcinoma? A phase III multicentre prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 2002; 95(8): 1685–95.
✍ Kazuhiro Hanazaki πŸ“‚ Article πŸ“… 2003 πŸ› Elsevier Science 🌐 English βš– 66 KB